pages/clinical.md
... ...
@@ -8,7 +8,7 @@ link-citations: true
8 8
9 9
|Gene|Status|Type|Entity|Therapy|Biomarker?|
10 10
|-|-|-|-|
11
-|[BCL2](/BCL2)|not approved|therapeutic target||venetoclax||
11
+|[BCL2](/BCL2)|not approved|DLBCL|therapeutic target||venetoclax||
12 12
|[BTK](/BTK#clinical-relevance)|not approved|DLBCL|therapeutic target|ibrutinib|ABC gene expression signature, MCD genetic subgroup|
13 13
|[CD79B](/CD79B#clinical-relevance)|DLBCL|therapeutic target|polatuzumab vedotin|ABC gene expression signature|
14 14
|[EZH2](/EZH2#clinical-relevance)|FL|therapeutic target|tazemetostat|Mutation|